ELCC Updates in Immunotherapy and Beyond for Non–Small Cell Lung Cancer - Episode 6
Dr Solange Peters reviews data on the efficacy and toxicities of first-line nivolumab and ipilimumab for metastatic non-squamous NSCLC.
Sponsored in part by Regeneron. Content independently created by OncLive.